CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 79  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1232
LYS 10.0154
GLU 20.0255
LEU 30.0353
ARG 40.0454
CYS 50.0123
GLN 60.0321
CYS 70.0323
ILE 80.0081
LYS 90.0329
THR 100.0151
TYR 110.0140
SER 120.0149
LYS 130.0250
PRO 140.0280
PHE 150.0163
HIS 160.0199
PRO 170.0230
LYS 180.0349
PHE 190.0333
ILE 200.0183
LYS 210.0327
GLU 220.0197
LEU 230.0154
ARG 240.0254
VAL 250.0240
ILE 260.0189
GLU 270.0169
SER 280.0234
GLY 290.1232
PRO 300.0422
HIS 310.0104
CYS 320.0325
ALA 330.0470
ASN 340.0414
THR 350.0156
GLU 360.0168
ILE 370.0232
ILE 380.0262
VAL 390.0152
LYS 400.0107
LEU 410.0104
SER 420.0162
ASP 430.0399
GLY 440.0198
ARG 450.0124
GLU 460.0195
LEU 470.0260
CYS 480.0284
LEU 490.0147
ASP 500.0109
PRO 510.0112
LYS 520.0140
GLU 530.0103
ASN 540.0156
TRP 550.0157
VAL 560.0135
GLN 570.0220
ARG 580.0209
VAL 590.0154
VAL 600.0143
GLU 610.0090
LYS 620.0107
PHE 630.0123
LEU 640.0255
LYS 650.0504
ARG 660.0326
ALA 670.0445
GLU 680.0288
ASN 690.0341

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.